Phase Ib study of dabrafenib, trametinib, irinotecan and cetuximab in BRAF V600Emutated metastatic colorectal cancer.

被引：0
|
作者：
Chen, Yungchang
Li, Xiaoqian
Man Yuxin
Hu, Hai
Wang, Liyang
Zhang, Zhixuan
Chen, Ping
Liu, Yang
Lu, Jin
Lin, Tongyu
机构：
[1] Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Ctr, Sichuan Canc Hosp & Inst, Chengdu, Peoples R China
[2] Shandong Acad Med Sci, Shandong Canc Hosp, Dept Med Oncol, Jinan 250117, Peoples R China
[3] Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Ctr, Dept Pathol,Sichuan Canc Hosp & Inst, Chengdu, Sichuan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
156
引用
收藏
页码：156 / 156
页数：1
相关论文
共 50 条
  • [41] Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer
    Michele Moschetta
    Gabriel Mak
    Joana Hauser
    Catriona Davies
    Mario Uccello
    Hendrik-Tobias Arkenau
    [J]. Experimental Hematology & Oncology, 6
  • [42] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
    Lieberman, Jeffrey A.
    Dosovitz, Simon M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (09): : 879 - 879
  • [43] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
    Kopetz, S.
    Grothey, A.
    Yaeger, R.
    Van Cutsem, E.
    Desai, J.
    Yoshino, T.
    Wasan, H.
    Ciardiello, F.
    Loupakis, F.
    Hong, Y. S.
    Steeghs, N.
    Guren, T. K.
    Arkenau, H. -T.
    Garcia-Alfonso, P.
    Pfeiffer, P.
    Orlov, S.
    Lonardi, S.
    Elez, E.
    Kim, T. -W.
    Schellens, J. H. M.
    Guo, C.
    Krishnan, A.
    Dekervel, J.
    Morris, V.
    Calvo Ferrandiz, A.
    Tarpgaard, L. S.
    Braun, M.
    Gollerkeri, A.
    Keir, C.
    Maharry, K.
    Pickard, M.
    Christy-Bittel, J.
    Anderson, L.
    Sandor, V.
    Tabernero, J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17): : 1632 - 1643
  • [44] Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer
    Moschetta, Michele
    Mak, Gabriel
    Hauser, Joana
    Davies, Catriona
    Uccello, Mario
    Arkenau, Hendrik-Tobias
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 5
  • [45] Irinotecan combined with Panitumumab or cetuximab as third-line treatment for metastatic colorectal cancer.
    Braghiroli, Maria Ignez
    Batistuzzo Vicentini, Maria Fernanda
    da Fonseca, Leonardo Gomes
    Souza, Karla Teixeira
    Bonadio, Renata Colombo
    Melro Braghiroli, Oddone Freitas
    Machado Mathias, Maria Cecilia
    Talans, Aley
    Zambrano Mendoza, Maria Elizabeth
    Martins, Juliana Goes
    Sabagga, Jorge
    Motta Venchiarutti Moniz, Camila Venchiarutti
    Hoff, Paulo Marcelo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15551 - E15551
  • [46] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
    Roviello, Giandomenico
    D'Angelo, Alberto
    Petrioli, Roberto
    Roviello, Franco
    Cianchi, Fabio
    Nobili, Stefania
    Mini, Enrico
    Lavacchi, Daniele
    [J]. TRANSLATIONAL ONCOLOGY, 2020, 13 (09):
  • [47] Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II)
    Atkinson, Victoria
    Sandhu, Shahneen
    Hospers, Geke
    Long, Georgina, V
    Aglietta, Massimo
    Ferrucci, Pier F.
    Tulyte, Skaiste
    Cappellini, Gian Carlo Antonini
    Soriano, Virtudes
    Ali, Sayed
    Poprach, Alexandr
    Cesas, Alvydas
    Rodriguez-Abreu, Delvys
    Lau, Mike
    de Jong, Egbert
    Legenne, Philippe
    Stein, Dara
    King, Brianna
    van Thienen, Johannes, V
    [J]. MELANOMA RESEARCH, 2020, 30 (03) : 261 - 267
  • [48] Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib
    Noeparast, Amir
    Teugels, Erik
    Giron, Philippe
    Verschelden, Gil
    De Brakeleer, Sylvia
    Decoster, Lore
    De Greve, Jacques
    [J]. ONCOTARGET, 2017, 8 (36) : 60094 - 60108
  • [49] Combination therapy of dabrafenib plus trametinib in patients with BRAF V600E-mutated biliary tract cancer
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Brandi, Giovanni
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2021, 20 (05) : 506 - 507
  • [50] Pilot study of vemurafenib and panitumumab combination therapy in patients with BRAF V600E mutated metastatic colorectal cancer.
    Yaeger, Rona D.
    Cercek, Andrea
    O'Reilly, Eileen Mary
    Reidy, Diane Lauren
    Kemeny, Nancy E.
    Wolinsky, Tamar
    Gollub, Marc J.
    Lacouture, Mario E.
    Rosen, Neal
    Vakiani, Efsevia
    Saltz, Leonard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
12345